Modulators of cellular adhesion

Details for Australian Patent Application No. 2004287875 (hide)

Owner SARcode Corporation

Inventors Oslob, Johan D.; Barr, Kenneth; Zhong, Min; Shen, Wang

Agent Davies Collison Cave

Pub. Number AU-B-2004287875

PCT Pub. Number WO2005/044817

Priority 60/517,535 05.11.03 US; 60/560,517 08.04.04 US

Filing date 5 November 2004

Wipo publication date 19 May 2005

Acceptance publication date 2 June 2011

International Classifications

C07D 217/06 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 407/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/044817 Priority application(s): WO2005/044817

22 October 2009 Assignment before Grant

  Sunesis Pharmaceuticals, Inc. The application has been assigned to SARcode Corporation

2 June 2011 Application Accepted

  Published as AU-B-2004287875

29 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004287879-Antagonist anti-CD40 monoclonal antibodies and methods for their use

2004287874-Manufacture of higher hydrocarbons from methane, via methanesulfonic acid, sulfene, and other pathways